GlassScriptPhysician profile
Mathew A Page
NPI 1710002886
$1,246.67
in general payments reported to CMS, 2019-2025
15 companies · $87.09 in 2025
The $87.09 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2021: $18.67 · 2023: $76.65 · 2024: $936 · 2025: $87.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $747 · Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $746.57 |
| Food and Beverage | $353.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $531.83 | 2024-2025 | |
| Arthrex, INC. | $333.36 | 2024 | |
| Paragon 28, INC. | $93.25 | 2019-2025 | Bun-Yo-Matic |
| Orthofix Medical, INC. | $42.47 | 2019-2025 | Physio-Stim |
| Smith+Nephew, INC. | $42.32 | 2019-2023 | Collagenase Santyl |
| Stryker Corporation | $42.11 | 2024 | N/A |
| Horizon Therapeutics Plc | $22.24 | 2023 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $20.30 | 2025 | |
| Wright Medical Technology, INC. | $19.81 | 2019 | |
| Mimedx Group, INC. | $19.79 | 2024 | |
| Paratek Pharmaceuticals, INC. | $19.61 | 2025 | Nuzyra |
| Nevro Corp. | $18.07 | 2024 | Senza |
| Merck Sharp & Dohme LLC | $16.02 | 2019 | |
| Arthrosurface Incorporated | $13.63 | 2019 | |
| Linvatec Corporation | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.